en
Feedback
Dr John B.

Dr John B.

Open in Telegram

Scientist, lecturer & father | Whistleblower

Show more

πŸ“ˆ Analytical overview of Telegram channel Dr John B.

Channel Dr John B. (@drjohnb) in the English language segment is an active participant. Currently, the community unites 25 340 subscribers, ranking 827 in the Medicine category and 1 740 in the USA region.

πŸ“Š Audience metrics and dynamics

Since its creation on Π½Π΅Π²Ρ–Π΄ΠΎΠΌΠΎ, the project has demonstrated rapid growth, gathering an audience of 25 340 subscribers.

According to the latest data from 15 August, 2025, the channel demonstrates stable activity. Although there has been a change in the number of participants by -221 over the last 30 days and by 0 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 0%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.
  • Thematic interests: Content is focused on key topics such as covid-19, vaccine, clot, patient, mrna.

πŸ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
β€œScientist, lecturer & father | Whistleblower”

Thanks to the high frequency of updates (latest data received on 16 August, 2025), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

25 340
Subscribers
No data24 hours
-397 days
-22130 days
Posts Archive
Syncopes, paresis & loss of vision after COVID-19 mRNA-based vaccination & SARS-CoV-2 infection: https://link.springer.com/ar
Syncopes, paresis & loss of vision after COVID-19 mRNA-based vaccination & SARS-CoV-2 infection: https://link.springer.com/article/10.1007/s15010-024-02439-y - "6 h after vaccination, the patient developed severe cephalgia & dizziness lasting for several days" - "Spontaneous syncope occurred 20–30 times over the following 2 weeks. Even though the syncopes disappeared, the patient continued to observe irregular heartbeats. ... he reported new onset of fatigue, brain fog, acral paresthesia, paresis of forearm extensors and Mm. quadriceps femoris, disseminated fasciculations & urticaria in the weeks following the vaccination" - "143 days after vaccination, the patient suffered a PCR confirmed SARS-CoV-2 infection, and the symptoms experienced after vaccination exacerbated" - "The details on the mechanisms underlying adverse side effects caused by mRNA-based vaccines remain unclear" - "Further mechanistic research assessing the pathologies that may trigger mRNA vaccine-associated symptoms are urgently needed"

In Germany, there is now a laboratory where you can get tested to see if you have components of the mRNA vaccine in your body
In Germany, there is now a laboratory where you can get tested to see if you have components of the mRNA vaccine in your body (blood, tissue samples, etc.). -> https://inmodia.de/en/ The Institute of Molecular Diagnostics (INMODIA GmbH) offers detection of: - Spike protein - β€˜Vaccine mRNA’ (modRNA) - Contaminating DNA (plasmid DNA) These components can be detected in the following sample materials: - Tissue samples (biopsy or autopsy materials, fixed or unfixed) - Blood plasma - Cerebrospinal fluid - Immune cells from whole blood or cerebrospinal fluid It's great that a service like this is now available! I expect that many more such laboratories will be opened worldwide in the near future, or that existing laboratories will start offering these services...

(7/n) Systematic studies are now needed to investigate these large clots using ThT-based fluorescence microscopy and, ideally
(7/n) Systematic studies are now needed to investigate these large clots using ThT-based fluorescence microscopy and, ideally, staining of NETs, as well as quantification of the amyloid fibrin microclot concentration (and size distribution) in plasma. This would actually be a topic for a @Nature or @ScienceMagazine paper – which research group dares to tackle this hot and difficult topic? For an earlier analysis of these clots, see my older post: https://x.com/DrJohnB2/status/1807188321665212922

(6/n) The fact that these clots stain positive for ThT is not good news, as it indicates that these clots are special and can
(6/n) The fact that these clots stain positive for ThT is not good news, as it indicates that these clots are special and cannot be easily dissolved by the body through fibrolysis. Presumably, these clots are also full of neutrophil extracellular traps (NETs), as has already been shown for amyloid-fibrin microclots (which are probably the smaller form of these macroclots) [1]: [1] https://www.researchsquare.com/article/rs-4666650/v1

(5/n)
(5/n)

(4/n)
(4/n)

(3/n)
(3/n)

(2/n)
(2/n)

(1/n) Important discovery regarding the special thrombi (clots) observed by various embalmers and pathologists: staining with
(1/n) Important discovery regarding the special thrombi (clots) observed by various embalmers and pathologists: staining with the sensitive amyloid dye Thioflavin T (ThT) is positive, i.e. they are probably amyloid-like thrombi! Here are fluorescence microscopy images published by Richard Hirschman (@r_hirschman) and Greg (@Greg21143362):

45 cases of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: https://www.elsevier.es/es-revista-neurolog
45 cases of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: https://www.elsevier.es/es-revista-neurologia-english-edition--495-avance-resumen-thrombosis-with-thrombocytopenia-syndrome-following-S2173580824000828 "One-quarter of patients died, and increased risk of death was associated with severe thrombocytopenia and presence of intracranial haemorrhage."

COVID-19 vaccination: https://www.elsevier.es/es-revista-neurologia-english-edition--495-avance-resumen-thrombosis-with-throm
COVID-19 vaccination: https://www.elsevier.es/es-revista-neurologia-english-edition--495-avance-resumen-thrombosis-with-thrombocytopenia-syndrome-following-S2173580824000828 "One-quarter of patients died, and increased risk of death was associated with severe thrombocytopenia and presence of intracranial haemorrhage."

45 cases of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: https://www.elsevier.es/es-revista-neurologia-english-edition--495-avance-resumen-thrombosis-with-thrombocytopenia-syndrome-following-S2173580824000828 "One-quarter of patients died, and increased risk of death was associated with severe thrombocytopenia and presence of intracranial haemorrhage."

"... our MR study provides evidence supporting a causal relationship between COVID-19 vaccination and ischemic stroke." -> ht
"... our MR study provides evidence supporting a causal relationship between COVID-19 vaccination and ischemic stroke." -> https://www.strokejournal.org/article/S1052-3057(24)00556-1/fulltext

The plasmid DNA contained in mRNA vaccines can integrate into the genome of normal cells! Important experimental work by Prof
The plasmid DNA contained in mRNA vaccines can integrate into the genome of normal cells! Important experimental work by Prof. Buckhaults. https://x.com/P_J_Buckhaults/status/1861083163868672204

Matrix metalloproteinase-9 (MMP-9) is significantly elevated in the serum of long COVID patients: https://pmc.ncbi.nlm.nih.go
Matrix metalloproteinase-9 (MMP-9) is significantly elevated in the serum of long COVID patients: https://pmc.ncbi.nlm.nih.gov/articles/PMC11472557/ - Microglia release MMP-9 when stimulated by SARS-CoV-2 Spike protein - "MMP-9 can disrupt the polysaccharide scaffolding of the brain matrix & digest tight junction proteins, thus disrupting neuronal connectivity. MMP-9 can cause vascular inflammation and increase blood brain barrier (BBB) permeability" (The COVID-19 vacciantion status of the study participants was not taken into account) (An increase in MMP-9 has been documented in patients with systemic inflammation following COVID-19 vaccination: https://journals.lww.com/jcma/fulltext/2023/09000/elevated_serum_levels_of_t_cell_immunoglobulin_and.8.aspx)

Normocomplementemic urticarial vasculitis (UV) following influenza vaccination: https://www.dovepress.com/normocomplementemic
Normocomplementemic urticarial vasculitis (UV) following influenza vaccination: https://www.dovepress.com/normocomplementemic-urticarial-vasculitis-following-influenza-vaccinat-peer-reviewed-fulltext-article-IMCRJ "The exact mechanism underlying the development of UV following vaccination remains unclear." "Accumulation of further cases and research is required to investigate the clinical course and underlying mechanisms of vaccine-induced UV."

Secondary T-cell deficiency (particularly affecting CD4 T cells) & chronic spontaneous urticaria after COVID-19 vaccination:
Secondary T-cell deficiency (particularly affecting CD4 T cells) & chronic spontaneous urticaria after COVID-19 vaccination: https://www.jaci-global.org/article/S2772-8293(24)00135-8/fulltext - "The precise mechanism underlying this occurrence remains unknown, although there have been numerous reports highlighting the association between COVID-19 vaccination and autoimmune disorders." - During his treatment period, he received another COVID-19 vaccine, got COVID-19, and the doctors administered additional vaccines (pneumococcal conjugate vaccine 13-valent, herpes zoster vaccine, pneumococcal polysaccharide vaccine 23-valent, and diphtheria, tetanus, and pertussis vaccine) "to prevent further complications."

Otitis media with ANCA-associated vasculitis following COVID-19 mRNA vaccination -> https://pubmed.ncbi.nlm.nih.gov/39344100/
Otitis media with ANCA-associated vasculitis following COVID-19 mRNA vaccination -> https://pubmed.ncbi.nlm.nih.gov/39344100/ "The pathogenesis of adverse events following COVID-19 vaccination are still unclear. This report has indicated that ANCA-associated vasculitis can be related to COVID-19 mRNA vaccines. As our knowledge of autoimmune disease developing after COVID-19 vaccination is still in the accumulation phase, it is relevant to amass such case reports and use them for assistance in diagnosis in the future."

Type 1 diabetes mellitus caused by COVID-19 mRNA vaccination: A case report and literature review of 17 published cases -> ht
Type 1 diabetes mellitus caused by COVID-19 mRNA vaccination: A case report and literature review of 17 published cases -> https://pmc.ncbi.nlm.nih.gov/articles/PMC11447533/ "New-onset type 1 DM has been reported after COVID-19 mRNA vaccination. Clinicians should maintain a high index of suspicion and pursue early testing for the same to reduce adverse outcomes and improve long-term prognosis."

Guillain BarrΓ© Syndrome (GBS) 4 weeks after receiving the COVID-19 vaccine -> https://pmc.ncbi.nlm.nih.gov/articles/PMC114572
Guillain BarrΓ© Syndrome (GBS) 4 weeks after receiving the COVID-19 vaccine -> https://pmc.ncbi.nlm.nih.gov/articles/PMC11457283/ Case of a 66-year-old woman. She died. "Despite the treatment, a deterioration of respiratory function led the patient to premature mortality."